These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus. Yachimski P; Peek RM Cancer Prev Res (Phila); 2011 Jun; 4(6):783-6. PubMed ID: 21636544 [TBL] [Abstract][Full Text] [Related]
12. Difluoromethylornithine and ethylglyoxal bis(guanylhydrazone) as inhibitors of human renal carcinoma cell proliferation and polyamine metabolism. Sjöholm A; Larsson R; Nygren P Anticancer Res; 1993; 13(4):979-83. PubMed ID: 8352568 [TBL] [Abstract][Full Text] [Related]
13. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine. Pfaller MA; Riley J; Gerarden T J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402 [TBL] [Abstract][Full Text] [Related]
14. Chemopreventive studies in Barrett's esophagus: a model premalignant lesion for esophageal adenocarcinoma. Garewal HS; Sampliner RE; Fennerty MB J Natl Cancer Inst Monogr; 1992; (13):51-4. PubMed ID: 1389696 [TBL] [Abstract][Full Text] [Related]